Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kenneth Cavallari

Dentist, Periodontics Virginia Beach, VA Doctor of Dentistry

NPI 1033370598 CMS profile 46542

984 First Colonial Rd, Suite 300, Virginia Beach, VA 23454

Open in the dashboard

General payments

$22,130

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kenneth Cavallari of Virginia Beach, VA is reported in the CMS Open Payments database as having received $22,130 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45 2
2024 General $63 2
2023 General $6,568 12
2022 General $2,093 17
2021 General $461 16
2020 General $8,147 11
2019 General $4,752 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Cavallari
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Kenneth Cavallari were reported at $45. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Kenneth Cavallari Dentist, Periodontics median Middle half National median
2019 $4,752 $129 $42–$367 $163
2020 $8,147 $90 $35–$265 $114
2021 $461 $125 $42–$411 $132
2022 $2,093 $123 $43–$364 $149
2023 $6,568 $125 $45–$358 $160
2024 $63 $119 $42–$350 $164
2025 $45 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nobel Biocare USA $15,214 55 payments
  2. Geistlich Pharma, North America, Inc. $3,578 4 payments
  3. Straumann USA LLC $3,110 6 payments
  4. Benco Dental Supply Co. $111 1 payment
  5. Dentsply Sirona Inc $97 2 payments
  6. Salvin Dental Specialties, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $9,480 3 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $4,000 1 payment
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 payment
  4. Food and Beverage $2,039 61 payments
  5. Education $2,000 1 payment
  6. Grant $1,500 1 payment
  7. Gift $111 1 payment
Products named General payments · program years 2019–2025
  1. NOBELACTIVE Dental implant $9,750 15 payments
  2. NOBELPARALLEL $9,750 15 payments
  3. NOBELPROCERA $5,161 10 payments
  4. NOBELSPEEDY $5,161 10 payments
  5. NOBELREPLACE Dental implant $5,145 9 payments
  6. EDUCATION $4,000 1 payment
  7. Bio-Gide $2,000 1 payment
  8. NOBELACTIVE Dental implant $683 16 payments
  9. NOBELREPLACE Dental implant $508 13 payments
  10. SYMBIOS $79 1 payment
  11. Other $191 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

864

Median for Dentist: 47

Drug cost

$3,627

Median for Dentist: $159

Branded share of claims

19.3%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 255 $1,006
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 127 $623
Amoxicillin Generic 147 $612
Dexamethasone Generic 137 $571
Doxycycline Hyclate Generic 42 $324
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $142
Acetaminophen-Codeine Acetaminophen With Codeine Brand 18 $99
Diazepam Generic 60 $89
Azithromycin Generic 28 $67
Tramadol Hcl Generic 17 $60

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record